Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by General and Acute Care Hospital Economic Experts

Analysis of: Doctors fail at fiscal prognoses (www.orlandosentinel.com)
• Patients have generally expected their physicians to disregard costs when determining a treatment plan.  "Whatever's best, doc." • It is unusual for us docs to know what things cost in the first place. • As patients are increasingly expected to assume a greater financial stake...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: Hospital-borne ailments face Medicare budget ax (www.indystar.com)
Medical errors and nosocomial infections continue to be on the radar despite several years of heightened attention and regulatory prodding. There has been no requirement or incentive to document how much of each patient's cost is due to avoidable errors or complications. It makes sense that Medicare...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: Doctors fail at fiscal prognoses (www.orlandosentinel.com)
Increasingly patients are being hit with higher out of pocket costs and it is a sad, unfair reality that patients might have to balance necessary treatment against the financial burden they might incur. Doctors have  a role in educating patients on the cost of alternative treatments offered. The...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: Meta-Analysis Links Rosiglitazone (Avandia) to Risk of Myocardial Infarction (www.medpagetoday.com)
This report raises more questions than answers. It is important because it suggests more work be done in several areas 1. A full scale study, not just a meta-analysis is needed. Also what are the risks of related drugs like Actos? 2. The Feds need to get serious about creating a robust, responsible...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: Clinton Says 66 Developing Nations To Get Cheaper AIDS Drugs (www.medicalnewstoday.com)
The fact that this deal was successfully brokered is a victory for HIV patients, poor countries and the free market. As pharmaceutical companies compete to get market share and to win the PR war, they will enter into deals such as these more and more. This is one case in which everyone wins.
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: SPOTLIGHT: The risks of medical tourism (www.fiercehealthcare.com)
The idea of medical tourism is not entirely new, but has become an increasing trend largely for cost reasons. Many patients equate quality of care with "US-equivalent" or even "US-associated". Interestingly the JCAHO which accredits US hospitals and programs has been expanding its scope internationally to...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: Abbott Announces FDA Clearance And Launch Of New FreeStyle Lite™ Blood Glucose Monitoring System (www.medicalnewstoday.com)
  Abbott's new FreeStle meter does offer some good features, but it will be difficult for them to break through in a crowded market. Abbott needs to launch an adverising campaign to push the product even as it provides education as to how to best use the meter. Clinicians and Diabetes Educators...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: FDA Approves Antibiotic Ointment For Children And Adults - Altabax (retapamulin Ointment) (www.medicalnewstoday.com)
The approval of this new drug is very good news as long as it's used per approved indications. This drug is new in a real way since it has  a novel mode of action. It's exciting that it has a short course; and since it's topical it can be prescribed even to young kids who have a difficult...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: JUSTICES UPHOLD BAN ON ABORTION PROCEDURE (www.cnn.com)
It was hardly surprising that this court upheld a ban on late term abortions. While it is true that the legal system reflects the values of society, it is becoming more diffuclt to separate legal decisions from political decisions. Judges increasingly tend to vote their political beliefs in favor...
Glen McDaniel, MS, MBA, President and Chief Executive Officer
Glen McDaniel, MS, MBA, President and Chief Executive Officer
GM Global
Analysis of: Medicaid bill would reward doctors for patient care (www.belleville.com)
As I have written elsewhere, P4P as a concept is really a given and, practiced well, is beneficial to patients and payors equally. The entire healthcare system benefits when evidence-based medicine is practiced and patients are treated according to the best science available, rather than by the...

Previous Page : 1 2 3 4 5 6 7 8 9 Next41 to 50 of 82

Analytics


Generated at 2009-01-08T13:34:52.320